Services

The facility's aim is to provide internal and external users a broad range of services based on its long-standing and diverse expertise in the development, manufacture and therapeutic use of advanced-therapy medicinal products (ATMP) and tissue engineering products (TEP) and their regulatory drug approval.

The GMP core offers a unique infrastructure for applied biomedical research: GMP-conform production sites with state-of-the-art equipment as well as medico-legal competence.

Due to the long lasting, sound expertise within this cluster we were already able to implement standard operating procedures (SOPs) for the generation of GMP-grade Mesenchymal Stromal Cells (MSC), regulatory T-lymphocytes (Treg) and virus-specific T-lymphocytes.

Implemented protocols and cell types